Benefits of Breast Cancer Index

Susan K. Boolbol, MD

Video Categories: PMO Interview with the Innovator Series: Volume 8

Dr Stephen C. Malamud and Dr Susan K. Boolbol consider the clinical utility of the Breast Cancer IndexSM (BCI) as a test that separates those patients who are more likely to benefit from those who are unlikely to benefit from extended endocrine therapy.

Related Videos

January 4, 2017

Serotonin and Carcinoid Tumors

Hal Gerstein, MD, details this neurotransmitter’s role in the development of carcinoid tumors and carcinoid syndrome. 

October 6, 2014

Managing and Navigating Patients with Polycythemia Vera

Emily A. Knight, RN of the Mayo Clinic in Scottsdale, AZ, describes issues faced in managing and navigating patients with polycythemia Supported through funding from Incyte